(SPRO) Spero Therapeutics - Performance 106.6% in 12m
SPRO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-75.41%
#120 in Peer-Group
Rel. Strength
94.53%
#417 in Stock-Universe
Total Return 12m
106.57%
#12 in Peer-Group
Total Return 5y
-76.22%
#91 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 2.89 USD |
| 52 Week Low | 0.56 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.20 |
| Buy/Sell Signal +-5 | -0.04 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SPRO (106.6%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
9.2% | 80.8% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.02% | -1.47% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
10.1% | 2.09% | 57% | 26.2 | 13.8 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
3.05% | 33.4% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.43% | -8.71% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
10.5% | 38.9% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
-0.15% | 37.3% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.39% | 16% | 11.2% | 28.1 | 14.3 | 0.59 | -62.1% | -19.3% |
Performance Comparison: SPRO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SPRO
| Total Return (including Dividends) | SPRO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 310.14% | 7.80% | 1.73% |
| 3 Months | 263.52% | -2.75% | 8.59% |
| 12 Months | 106.57% | -10.76% | 11.46% |
| 5 Years | -76.22% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | SPRO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 94.4% | 84.2% | 69.9% |
| 3 Months | 25.1% | -2.8% | 69.3% |
| 12 Months | -65.1% | -77.8% | 43.2% |
| 5 Years | -79.8% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #1 | 280.46% | 303.16% |
| 3 Month | #3 | 273.80% | 234.76% |
| 12 Month | #12 | 131.48% | 85.34% |
| 5 Years | #90 | -70.80% | -88.63% |
FAQs
Does Spero Therapeutics (SPRO) outperform the market?
Yes,
over the last 12 months SPRO made 106.57%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.76%.
Over the last 3 months SPRO made 263.52%, while XBI made -2.75%.
Performance Comparison SPRO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SPRO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 13.6% | 308.4% | 165.1% | 95% |
| US NASDAQ 100 | QQQ | 13.8% | 307.9% | 164.9% | 95% |
| German DAX 40 | DAX | 16.5% | 310.8% | 149.7% | 78% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 13.5% | 311% | 164.6% | 94% |
| Hongkong Hang Seng | HSI | 12.2% | 304.4% | 148.2% | 80% |
| India NIFTY 50 | INDA | 14.8% | 310.1% | 166.5% | 107% |
| Brasil Bovespa | EWZ | 11.7% | 310.8% | 147.9% | 99% |
SPRO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 14.3% | 307.7% | 162.3% | 83% |
| Consumer Discretionary | XLY | 13.4% | 311.8% | 174.2% | 88% |
| Consumer Staples | XLP | 14.1% | 308.9% | 164.5% | 98% |
| Energy | XLE | 7.6% | 307.4% | 164.1% | 104% |
| Financial | XLF | 15.8% | 312.3% | 162.8% | 82% |
| Health Care | XLV | 11.9% | 306.9% | 167.1% | 112% |
| Industrial | XLI | 14.8% | 309.2% | 159.9% | 88% |
| Materials | XLB | 13.7% | 308.6% | 165.6% | 107% |
| Real Estate | XLRE | 13.2% | 308.2% | 165% | 94% |
| Technology | XLK | 12.9% | 307.3% | 164.1% | 100% |
| Utilities | XLU | 12.9% | 307.9% | 158% | 87% |
| Aerospace & Defense | XAR | 13.5% | 302% | 146.4% | 65% |
| Biotech | XBI | 14% | 302.3% | 175% | 117% |
| Homebuilder | XHB | 14.2% | 317% | 181.7% | 117% |
| Retail | XRT | 17% | 309% | 173.1% | 106% |
SPRO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.8% | 295% | 156% | 101% |
| Natural Gas | UNG | 18% | 320.2% | 149.5% | 125% |
| Gold | GLD | 9.6% | 304.5% | 135% | 58% |
| Silver | SLV | 12.3% | 300% | 145.7% | 82% |
| Copper | CPER | 14.7% | 308.9% | 150.5% | 99% |
SPRO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 12.1% | 309.3% | 166.6% | 111% |
| iShares High Yield Corp. Bond | HYG | 13.1% | 309.8% | 161.6% | 98% |